Business
RSAMMD ACQUISITIONS LLC AND PROTEXT MOBILITY, INC. (TXTM) PLEASED TO ANNOUNCE ITS CHAIRMAN DR. AHMED JAMALOODEEN HAS RECEIVED THE HIGH HONOR OF BEING APPOINTED AS NATIONAL COMMODITY BOARD CHAIRMAN OF CANNABIS AND ALL INDIGENOUS FLORA
RSAMMD ACQUISITIONS LLC AND PROTEXT MOBILITY, INC. (TXTM) PLEASED TO ANNOUNCE ITS CHAIRMAN DR. AHMED JAMALOODEEN HAS RECEIVED THE HIGH HONOR OF BEING APPOINTED AS NATIONAL COMMODITY BOARD CHAIRMAN OF CANNABIS AND ALL INDIGENOUS FLORA.
About this update from Protext Mobility, Inc.
[{"type":"text","content":"\n Johannesburg, South Africa, June 30, 2022 (GLOBE NEWSWIRE) -- Republic of South Africa Medical Marijuana Dispensaries Acquisitions LLC (“RSAMMDA.LLC”) and Protext Mobility, Inc (OTC PINK: TXTM) are pleased to announce that its Chairman Dr. Ahmed Jamaloodeen (Dr.J) has received the high honor of being appointed as National Commodity Board Chairman of Cannabis and All Indigenous Flora.  As the largest agricultural Union, the Chairman will represent and interact with all stakeholders including but not limited to Government, both local and international Governments to set framework for the country of South Africa as it relates to Cannabis and all indigenous flora. Dr. Jamaloodeen commented, “This past Thursday, I had the distinct honor of accepting the appointment of National Commodity Board Chairman of Cannabis and Indigenous Flora in the Country of South Africa.  What full Union support means is enablement.  And now, with the acquisition complete Protext has management in place with the knowledge, relationships – governmental and other, compliance, resources, facilities, biomass, human capital and infrastructure that is invaluable.  The federally issued and gazetted licenses we are in possession of allow for cannabis and hemp import, export, grow & cultivation, research, testing , developing end product for global distribution, all of which are anticipated to be utilized by Protext with the end goal to commercialize the live plant extraction technology and bring superior end products to the market. Having technology that’s been proven to increase bioavailability by 10-15x greater is significant.  Additional testing is anticipated to be conducted over the next few weeks as we are in the process of bringing the kettle equipment back to the farm. The testing will focus on maximizing yield as well as testing various strains.”  Dr.J continued, “As we previously stated, but worth repeating, we entered into this transaction with Protext as we believe there to be numerous synergies by allowing access to certain assets of our established business’ with Protext as well as commercialize the Protext proprietary live plant extraction technology and processes into our existing hemp and cannabis infrastructure.  Prior to the merger, Protext had collaborated...